Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis

被引：0
作者：
Manzar, Daud
Suntres, Emmanuel [1 ]
Nair, Nikhil
Patel, Yash [1 ]
Abu-Hilal, Mohannad [2 ,3 ]
机构：
[1] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[2] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[3] McMaster Univ, Div Dermatol, 100 Main St West, Hamilton, ON L8P 1H6, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 01期
关键词：
abrocitinib; atopic dermatitis; creatine phosphokinase; dupilumab; JAK-inhibitor; upadacitinib;
D O I：
10.1016/j.jaad.2024.03.027
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：168 / 169
页数：2
相关论文
共 5 条
  • [1] Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study
    Beck, Lisa A.
    Thaci, Diamant
    Deleuran, Mette
    de Bruin-Weller, Marjolein
    Chen, Zhen
    Khokhar, Faisal A.
    Zhang, Meng
    Ozturk, Zafer E.
    Shumel, Brad
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1608 - 1616
  • [2] Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
    Guttman-Yassky, Emma
    Thaci, Diamant
    Pangan, Aileen L.
    Hong, H. Chih-ho
    Papp, Kim A.
    Reich, Kristian
    Beck, Lisa A.
    Mohamed, Mohamed-Eslam F.
    Othman, Ahmed A.
    Anderson, Jaclyn K.
    Gu, Yihua
    Teixeira, Henrique D.
    Silverberg, Jonathan I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (03) : 877 - 884
  • [3] ELUCIDATING THE MECHANISM UNDERLYING CREATINE PHOSPHOKINASE UPREGULATION WITH UPADACITINIB
    Queeney, Kara
    Housley, William
    Sokolov, Jeremy
    Long, Andrew
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 734 - 735
  • [4] Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results
    Silverberg, Jonathan, I
    De Bruin-Weller, Marjolein
    Bieber, Thomas
    Soong, Weily
    Kabashima, Kenji
    Costanzo, Antonio
    Rosmarin, David
    Lynde, Charles
    Liu, John
    Gamelli, Amy
    Zeng, Jiewei
    Ladizinski, Barry
    Chu, Alvina D.
    Reich, Kristian
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 977 - +
  • [5] Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis
    Wood, Hannah
    Chandler, Antoinette
    Nezamololama, Novin
    Papp, Kim
    Gooderham, Melinda J.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : 746 - 754
1